Anti ‐aquaporin‐4 positive‐to‐negative seroconversion in Latin American patients with neuromyelitis optica spectrum disorder treated with rituximab

ConclusionsTreatment with RTX in patients with seropositive AQP4-IgG NMOsd can lead to negative conversion, but our findings do not support a clinical reflection from this change. The role of monitoring for AQP4-IgG is yet to be defined in the Mexican NMOsd population.

Source: Clinical and Experimental Neuroimmunology - August 21, 2021 Category: Neurology Authors: Indhira Zabala ‐Ángeles, Christian García‐Estrada, Enrique Gómez‐Figueroa, Roberto Rodriguez‐Rivas, Edgar Higuera‐Gonzalez, Adriana Casallas‐Vanegas, Lucinda Aguirre‐Cruz, Teresa Corona‐Vázquez, José Flores‐Rivera, Verónic Tags: ORIGINAL ARTICLE Source Type: research